Pluvicto 2026 cleveland
Active Awarded Last action
- Contract number
- 36C25026F0204
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $501,670
Award facts
- Contract value 100% obligated
- $501,669.60 Current and potential, with all options
- Completion date 80% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- East Hanover, NJ 07936, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $167,223 | |
| Original award | $334,446 |
About this award
Veterans Integrated Service Network 10 issued a $501,669.60 delivery order to Novartis Pharmaceuticals Corporation on January 5, 2026, for PLUVICTO (Lutetium Lu-177 Vipivotide Tetra), a radiopharmaceutical for metastatic castration-resistant prostate cancer, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
The Pharmaceuticals and Drugs FSS is a multi-vendor GSA schedule serving the federal government's pharmaceutical procurement needs. Place of performance is East Hanover, New Jersey. The delivery order is firm fixed price with an ultimate completion date of December 31, 2026. No set-aside applies to this order.
Quick answers
Who was awarded contract 36C25026F0204?
36C25026F0204 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 5, 2026.
How much is contract 36C25026F0204 worth?
The government has obligated $501,670 on 36C25026F0204.
Is contract 36C25026F0204 an order under another contract?
Yes. 36C25026F0204 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25026F0204 competed?
The extent of competition for 36C25026F0204 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award